The Concise Guide to PHARMACOLOGY 2013/14: transporters.
about
Sphingosine-1-Phosphate Receptor-2 Antagonists: Therapeutic Potential and Potential RisksThe effects of microRNA on the absorption, distribution, metabolism and excretion of drugsRole of the MPTP in conditioning the heart - translatability and mechanismAnaesthetics as cardioprotectants: translatability and mechanismSomething old, something new and something very old: drugs for treating type 2 diabetesp38 MAPK in cardioprotection - are we there yet?Are cannabidiol and Δ(9) -tetrahydrocannabivarin negative modulators of the endocannabinoid system? A systematic reviewPotassium Channelopathies and Gastrointestinal UlcerationDopamine receptors - IUPHAR Review 13Developmental rodent models of fear and anxiety: from neurobiology to pharmacology.Mechanisms to medicines: elucidating neural and molecular substrates of fear extinction to identify novel treatments for anxiety disordersRegulatory role of the cannabinoid CB2 receptor in stress-induced neuroinflammation in mice.TRP channels in the skin.The histone acetylranseferase hMOF acetylates Nrf2 and regulates anti-drug responses in human non-small cell lung cancerIncreased drug resistance is associated with reduced glucose levels and an enhanced glycolysis phenotype.The TRPC channel blocker SKF 96365 inhibits glioblastoma cell growth by enhancing reverse mode of the Na(+) /Ca(2+) exchanger and increasing intracellular Ca(2+).Nucleoside transporters and human organic cation transporter 1 determine the cellular handling of DNA-methyltransferase inhibitors.Lysophospholipid receptor nomenclature review: IUPHAR Review 8.Purinergic neuromuscular transmission in the gastrointestinal tract; functional basis for future clinical and pharmacological studiesPharmacological manipulations in animal models of anorexia and binge eating in relation to humans.Fluoxetine elevates allopregnanolone in female rat brain but inhibits a steroid microsomal dehydrogenase rather than activating an aldo-keto reductase.Stereochemistry of mephedrone neuropharmacology: enantiomer-specific behavioural and neurochemical effects in ratsPharmacological profile of novel psychoactive benzofurans.Multimodal antidepressant vortioxetine increases frontal cortical oscillations unlike escitalopram and duloxetine--a quantitative EEG study in rats.Utilizing hydrogen sulfide as a novel anti-cancer agent by targeting cancer glycolysis and pH imbalance.Identification of novel insulin mimetic drugs by quantitative total internal reflection fluorescence (TIRF) microscopy.Pharmacokinetics, metabolism, and excretion of cycloastragenol, a potent telomerase activator in rats.Synthetic (+)-antroquinonol exhibits dual actions against insulin resistance by triggering AMP kinase and inhibiting dipeptidyl peptidase IV activitiesHydrogen peroxide stimulation of CFTR reveals an Epac-mediated, soluble AC-dependent cAMP amplification pathway common to GPCR signallingMolecular targets of the multifunctional iron-chelating drug, M30, in the brains of mouse models of type 2 diabetes mellitusSelective Na(+) /Ca(2+) exchanger inhibition prevents Ca(2+) overload-induced triggered arrhythmiasNeuroprotective effects of the anti-cancer drug sunitinib in models of HIV neurotoxicity suggests potential for the treatment of neurodegenerative disorders.A non-erythropoietic peptide derivative of erythropoietin decreases susceptibility to diet-induced insulin resistance in mice.In vitro, in vivo and ex vivo characterization of ibrutinib: a potent inhibitor of the efflux function of the transporter MRP1.Orexin/hypocretin role in reward: implications for opioid and other addictionsTargeting two-pore domain K(+) channels TREK-1 and TASK-3 for the treatment of depression: a new therapeutic concept.Ionic mechanisms underlying the negative chronotropic action of propofol on sinoatrial node automaticity in guinea pig heartPreventing leptin resistance by blocking angiotensin II AT1 receptors in diet-induced obese rats.Molecular mechanisms governing different pharmacokinetics of ginsenosides and potential for ginsenoside-perpetrated herb-drug interactions on OATP1B3.Presynaptic adenosine A2A receptors dampen cannabinoid CB1 receptor-mediated inhibition of corticostriatal glutamatergic transmission
P2860
Q26738344-BE755B84-8263-494E-98C3-EDF78A896653Q26822987-DAF9A55B-580E-43BB-8DC0-EC24B8B6C473Q26830560-62D1BCE7-E305-4FD5-BA80-76792081F4A8Q26863637-E3769201-9F97-4054-85E9-3F2225E48FFDQ26865663-396AEE6D-1BD7-4E35-A100-D5E80D421042Q27001653-D65CEA2B-82B2-42C0-B41A-EB416D8D88E2Q27005619-4E037D99-6C0B-4A66-8B55-E9AB24D08C39Q28072892-DBCEE952-7B97-4667-A05E-F1913DCCF009Q28256783-A635ACD2-31AE-40C0-A9C3-4F8F27413075Q28307680-88DBF88D-B584-4CF7-83F1-043ABA322C47Q28396555-3F2B5B23-49DA-4CA2-AA27-3E0E8D4F21F1Q30410119-0E533049-9A7A-4937-93B6-3FF654ACD64FQ33562177-C34F800C-1BD3-4447-9C97-98D645FEEC4CQ33842719-6FE8B821-0CD9-4709-BE22-2D50E1C1394AQ33842748-D3684645-E792-4B73-8E88-B5F6AB278BC2Q33929772-6E969943-5C7F-42C4-B1AB-3D7384C00D47Q34025097-414C6C22-85C6-4325-8AED-16FCF2AA4F90Q34025135-F1F81002-08A3-46C1-9464-1EE8DB48DC28Q34402767-C82AD0BA-23DA-45B7-B8E8-245C1D78D537Q34407191-F16FC963-9338-445D-BE1C-DA65EA9CD29CQ34435307-04C1D1E7-C478-49E7-99AD-8B24326FB6B9Q34440487-0CD749DC-69C3-4C2E-86EE-70F772A4CB3AQ34466872-575F81EA-E11A-41A1-9D24-B2984F6FE02AQ34559591-526AC644-6EDD-4B7E-B241-A221296C66A9Q34559610-963E25E1-D5A0-4AF8-ABC7-44F468102768Q34669726-1C9B247C-A2D4-4380-9016-8B4C61D9055EQ34677829-AD16E118-1705-4247-ADAE-61C0686351E7Q34795679-2B11DA1B-04B7-467B-9A2A-379F06346F6BQ34795751-689DFEBB-E71E-4105-A88F-058E937C4D40Q34914164-094E0A1F-231C-4808-89CC-3662BF269A74Q34914184-4EE2AD3F-43D9-4978-A552-AB344A71DD0AQ34914245-1CB2EEB2-394A-42CF-9A82-BE310F42EB73Q34914262-083DB658-1890-478A-BFD7-0DA8D54A06BDQ34914312-4EFB9E6F-283F-42F1-88C5-88D91695D417Q34939568-B4BBA1DE-B0B1-441E-8A3B-F1357991F965Q34994509-E6E2D3C7-D69D-457D-84A8-456AFF8316D5Q34994519-CF386B73-CF3E-4058-80EE-807A90604655Q34994537-B4418A85-6DC9-4426-80E3-46B8C52829E1Q35039217-9590A34D-C512-4313-A79C-2DA574BBF0F6Q35039222-274493CE-5137-4392-83AF-41B4289572E8
P2860
The Concise Guide to PHARMACOLOGY 2013/14: transporters.
description
2013 nî lūn-bûn
@nan
2013 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
The Concise Guide to PHARMACOLOGY 2013/14: transporters.
@ast
The Concise Guide to PHARMACOLOGY 2013/14: transporters.
@en
type
label
The Concise Guide to PHARMACOLOGY 2013/14: transporters.
@ast
The Concise Guide to PHARMACOLOGY 2013/14: transporters.
@en
prefLabel
The Concise Guide to PHARMACOLOGY 2013/14: transporters.
@ast
The Concise Guide to PHARMACOLOGY 2013/14: transporters.
@en
P2093
P2860
P50
P356
P1476
The Concise Guide to PHARMACOLOGY 2013/14: transporters.
@en
P2093
Anthony J Harmar
CGTP Collaborators
Helen E Benson
John A Peters
P2860
P304
P356
10.1111/BPH.12450
P407
P577
2013-12-01T00:00:00Z